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Introduction {#rcr2462-sec-0001}
============

Central neurogenic hyperventilation (CNH) is defined as hyperventilation caused by a central nervous disorder [1](#rcr2462-bib-0001){ref-type="ref"}. This pathology usually consists of deep, rapid breathing at a rate of at least 25 breaths/min. Only 37 cases of this rare condition have been reported since the first description was given by Plum and Sweanson in 1959 [1](#rcr2462-bib-0001){ref-type="ref"}. Most reported cases were associated with infiltrative lymphoma of the brainstem, but the mechanisms underlying CNH remain unclear. Seventeen cases of primary central nervous system lymphoma (PCNSL)‐induced CNH have been reported to date, and cases showing a normal respiratory rate have been extremely rare among these. Here, we describe a case of PCNSL‐induced CNH without tachypnoea. Comparing CNH cases without tachypnoea to CNH with tachypnoea might yield new insights into the mechanisms of CNH.

Case Report {#rcr2462-sec-0002}
===========

A 60‐year‐old human immunodeficiency virus‐negative man was admitted to our hospital with a 4‐day history of dyspnoea, appetite loss, and night sweats. He reported a history of blurred vision in both eyes for over 2 months before admission. He did not have any relevant medical history. Although his Glasgow Coma Scale score was 15, his conversation was slow and slightly constrained. Vital signs were normal, including regular breathing at a rate of 20 breaths/min. Respiratory sounds on auscultation were normal. Arterial blood gas (ABG) analysis in room air showed marked respiratory alkalosis (pH 7.62, PaCO~2~ 10.3 mmHg, PaO~2~ 130.8 mmHg, bicarbonate 10.4 mEq/L). Computed tomography (CT) of the chest showed patchy, upper lobe‐predominant, ground‐glass opacities in the periphery of both lungs and excluded pulmonary embolism (Fig. [1](#rcr2462-fig-0001){ref-type="fig"}A). Blood tests showed inflammation and liver dysfunction: white blood cell count, 10,300/μL; aspartate aminotransferase (AST), 164 IU/L; alanine aminotransferase (ALT), 291 IU/L; lactate dehydrogenase (LDH), 381 IU/L; alkaline phosphatase (ALP), 681 IU/L; gamma glutamyl transferase (γ‐GTP), 489 IU/L; C‐reactive protein (CRP), 17.2 mg/dL; and soluble interleukin‐2 receptor 430 U/mL. Results for markers of renal and thyroid function from blood tests were normal. Levels of serum prolactin, lactate, and ammonia were within the normal ranges. Urine ketone testing yielded negative results. The results of electro‐ and echocardiograms were also normal. The provisional diagnosis was atypical pneumonia, and intravenous levofloxacin was started at 500 mg/day. Pneumonia improved day by day, but dyspnoea and respiratory alkalosis without tachypnoea persisted (day 3: pH 7.59, PaCO~2~ 14.8 mmHg, PaO~2~ 136.7 mmHg, bicarbonate 13.9 mEq/L). The patient underwent brain magnetic resonance imaging (MRI) on hospital day 3 for further investigation, demonstrating hyperintensity of the left cerebral cortex, basal ganglia, corona radiata, midbrain, and ventral pons on fluid‐attenuated inversion recovery (FLAIR) images (Fig. [1](#rcr2462-fig-0001){ref-type="fig"}B--D). We therefore diagnosed CNH. The results of cerebrospinal fluid cytology (CSF) collected on day 4 were as follows: opening pressure 9 cm H~2~O, glucose 65 mg/dL (plasma glucose 102 mg/dL), protein 57 mg/dL, and 1 mononuclear cell/μL. CSF cytology was negative. As the mycoplasma antibody titre was positive at 1:160 according to a particle agglutination assay, we made a presumptive diagnosis of acute disseminated encephalomyelitis associated with mycoplasma pneumonia. Intravenous methylprednisolone pulse therapy (1000 mg/day for 3 days) was administered from day 6, 12, and 24, but this therapy was only partially effective. At the same time, a tumour‐like lesion in the left frontal lobe became larger during therapy and appeared quite obvious on his MRI of day 31 (Fig. [1](#rcr2462-fig-0001){ref-type="fig"}E,F); he underwent stereotactic brain biopsy on day 35, which demonstrated diffuse large B‐cell lymphoma. CT of the trunk showed no evidence of systemic spread, and PCNSL was finally diagnosed.

![(A) Patchy, upper lobe‐predominant, ground‐glass opacities in the periphery of both lungs from thoracic computed tomography on admission. (B--D) Brain magnetic resonance imaging in hospital day 3 shows hyperintensity of the left cerebral cortex, basal ganglia, corona radiata, midbrain, and ventral pons on fluid‐attenuated inversion recovery. (E) Tumour‐like lesion in the left frontal lobe on the brain MRI of day 3 (F) and day 31.](RCR2-7-e00462-g001){#rcr2462-fig-0001}

Discussion {#rcr2462-sec-0003}
==========

Hyperventilation is defined as increased airflow into the lung alveoli, eliminating more carbon dioxide than is produced, and is usually accompanied by tachypnoea. Several conditions stimulate the inspiratory centre (dorsal respiratory group (DRG)) and cause hyperventilation, such as hypoxia, metabolic acidosis, increased metabolic demands (fever, hyperthyroidism), salicylic acid use, pregnancy, or hyperventilation syndrome triggered by emotional upset [2](#rcr2462-bib-0002){ref-type="ref"}. We ruled out each of those conditions. Because a series of his ABG analysis showed extreme respiratory alkalosis, we examined brain MRI and diagnosed CNH. To date, 37 cases of CNH have been reported in the literature. PCNSL is the most common cause of CNH, and 17 cases of PCNSL‐induced CNH have been reported so far (Table [1](#rcr2462-tbl-0001){ref-type="table"}). However, only the present case and one other case presented by Adachi showed a normal respiratory rate [3](#rcr2462-bib-0003){ref-type="ref"}. In the case related by Adachi, brain MRI did not show any lesions suggesting infiltration of lymphoma, but CSF showed positive results. Our case showed negative CSF cytology but lymphomatous lesions in the ventral pons and midbrain on MRI, whereas most other cases of CNH with tachypnoea also show lymphoma in the dorsal pons, medulla, or meningeal space. We presume that lymphomatous meningitis and diffuse infiltration of lymphoma including the dorsal pons are possible causative factors for CNH with tachypnoea. Administration of morphine at 10--20 mg/day has been reported to reduce tachypnoea in several cases of CNH, except for cases of lymphomatous meningitis [4](#rcr2462-bib-0004){ref-type="ref"}. The underlying pathophysiological mechanisms of CNH have been suggested to involve direct infiltration of the respiratory control centres of the brainstem or stimulation of these centres by inflammatory cytokines secreted from neighbouring tumour tissues but are not yet fully understood [5](#rcr2462-bib-0005){ref-type="ref"}. Additional work to gain more understanding and insights into the mechanisms of CNH is needed by studying more cases of CNH with or without tachypnoea and by comparing those MRI images, CSF results, and possibly biopsy of the brain tissues. First and foremost, clinicians should keep in mind that some cases of CNH do not show tachypnoea.

###### 

Cases of central neurogenic hyperventilation caused by primary central nervous system lymphoma.

  Author                                                             Sex/age     Respiratoryrate   pH      PaCO~2~mmHg   HCO~3~ ^−^mmHg   Area of involvement
  ------------------------------------------------------------------ ----------- ----------------- ------- ------------- ---------------- ----------------------------------------------------------------------------------------------------
  Lange and Laszlo [6](#rcr2462-bib-0006){ref-type="ref"}            Male/51     32                7.58    12            19               Midbrain, pons (diffuse), meninges, occipital lobes
  Tinaztepe et al. [7](#rcr2462-bib-0007){ref-type="ref"}            Male/7      42--62            7.52    8.62          8.6              Pons, nucleus caudatus, thalamus, cerebral peducles
  Sunderrajan andPassamonte [8](#rcr2462-bib-0008){ref-type="ref"}   Male/41     26                7.62    7             12               Cerebral hemispheres
  Bateman et al. [9](#rcr2462-bib-0009){ref-type="ref"}              Male/62     26                7.61    12            12               Temporal lobes, right frontal lobe, right internal capsule
  Pauzner et al. [10](#rcr2462-bib-0010){ref-type="ref"}             Female/61   36--50            7.66    8             NS               Copus callosum, parietal regions
  Sugama et al. [11](#rcr2462-bib-0011){ref-type="ref"}              Female/58   25--30            7.603   10.5          10.4             Brain stem (diffuse), cerebral cortex, cerebellum, thalamus, basal ganglia
  Krendel et al. [12](#rcr2462-bib-0012){ref-type="ref"}             Female/52   30                7.63    9             NS               Leptomeninges, frontal lobes, left cortex, left striatum
  Karp and Nahum [13](#rcr2462-bib-0013){ref-type="ref"}             Male/57     40                7.53    15            12.1             Meninges
  Shibata et al. [14](#rcr2462-bib-0014){ref-type="ref"}             Female/72   Fast, deep        7.613   17.4          NS               Pons (diffuse), paraventricular hypothalamic nucleus, corpus callosum
  Chang [4](#rcr2462-bib-0004){ref-type="ref"}                       Female/40   35                7.65    9.7           11.1             Leptomeninges, left temporal lobe
  Sakamoto et al. [15](#rcr2462-bib-0015){ref-type="ref"}            Male/72     30                7.58    16.7          15.3             Pons (diffuse), medulla
  Shams et al. [16](#rcr2462-bib-0016){ref-type="ref"}               Male/54     23                7.58    16.8          16               Pons (dorsal), thalamus, internal capsule, corona radiata
  Tarulli et al. [17](#rcr2462-bib-0017){ref-type="ref"}             Male/87     \>25              7.6     14            NS               Midbrain (dorsal), right frontal lobe, left cerebellar hemisphere and penduncle
  Adachi [3](#rcr2462-bib-0003){ref-type="ref"}                      Female/51   16--20            7.64    6.7           NS               Leptomeninges
  Enam and Ali [18](#rcr2462-bib-0018){ref-type="ref"}               Male/47     47                7.54    30.2          16               Midbrain (diffuse), medulla, left cerebellar peduncle
  Yasunami et al. [19](#rcr2462-bib-0019){ref-type="ref"}            Male/68     28--32            7.564   11.4          10.4             Midbrain, pons (diffuse), right cerebellar peduncle, cerebellar hemisphere, thalamus, hypothalamus
  Pantelyat [5](#rcr2462-bib-0005){ref-type="ref"}                   Male/69     25--35            7.63    9             9.5              Midbrain, pons (dorsal), bilateral cerebral hemispheres, thalami
  Present case (2019)                                                Male/60     20                7.62    10.3          10.4             Midbrain, pons (ventral), left cerebral cortex, basal ganglia, corona radiata
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